LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
RDHL
RedHill Biopharma Ltd.
There isn't enough reported data to score RDHL yet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
RDHL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
RDHL's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | โ |
| Current | 46x | $1,427 | โ |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
RDHL PE Valuation
RDHL has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
RDHL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect RDHL's losses to shrink, with revenue growing.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over RDHL in the latest year-over-year earnings comparison.
RDHL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | $0.25 | +$120.25 |
| Q2 2023 | -$59.00 | +$99.35 |
| Q4 2022 | -$120.00 | +$98.35 |
| Q2 2020 | -$300.00 | -$153.15 |
| Q4 2019 | -$280.00 | -$103.15 |
| Q4 2018 | -$176.85 | +$83.15 |
| Q4 2017 | -$260.00 | +$890.00 |
RDHL has returned to profit: it earned $0.25 per share over the past year, after losing money the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over RDHL in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
RDHL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $4.1M | +59% |
| Q4 2024 | $5.5M | +382% |
| Q2 2024 | $2.6M | -52% |
| Q4 2023 | $1.1M | -96% |
| Q2 2023 | $5.4M | -83% |
| Q4 2022 | $30.4M | -31% |
| Q2 2022 | $31.5M | -25% |
| Q4 2021 | $43.7M | +3% |
RDHL's revenue has slid since its 2021 peak: $4M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -107% | -565 points |
| Q4 2024 | -113% | -57 points |
| Q2 2024 | -328% | -247 points |
| Q4 2023 | -1061% | -974 points |
| Q2 2023 | 457% | +560 points |
| Q4 2022 | -56% | +24 points |
| Q2 2022 | -82% | +52 points |
| Q4 2021 | -87% | +635 points |
RDHL's operating margin was โ107% last quarter, down 565 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.
RDHL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$5M | +$1.2M |
| Q4 2024 | -$3.2M | +$14.9M |
| Q2 2024 | -$6.2M | +$11.6M |
| Q4 2023 | -$18M | -$9.6M |
| Q2 2023 | -$17.8M | +$3.1M |
| Q4 2022 | -$8.5M | +$25.4M |
| Q2 2022 | -$20.9M | +$10.3M |
| Q4 2021 | -$33.9M | -$11.8M |
RDHL has burned cash in almost every quarter: โ$32M over the past year, against โ$81M the year before.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
RDHL Net Leverage
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
RDHL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.9 | Neutral |
| Stochastic | 2.1 | Oversold |
RDHL's weekly RSI is 31 (neutral) and its Stochastic is 2 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
RDHL PE vs Healthcare Sector
RDHL has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over RDHL on trend strength, trading above more of its moving averages.
RDHL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.45 | 16% below |
| 20 week MA | $0.58 | 34% below |
| 50 week MA | $0.84 | 55% below |
| 100 week MA | $1.75 | 78% below |
| 200 week MA | $20.6 | 98% below |
RDHL is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over RDHL on returns for 2026, with the stronger performance.
RDHL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,050.0 | $9,320.0 | +54% |
| 2021 | $9,320.0 | $2,640.0 | -72% |
| 2022 | $2,640.0 | $158.5 | -94% |
| 2023 | $158.5 | $36.5 | -77% |
| 2024 | $36.5 | $6.91 | -81% |
| 2025 | $6.91 | $1.14 | -84% |
| 2026 YTD | $1.14 | $0.38 | -67% |
RDHL has finished five years in a row lower, and it's down 67% so far in 2026.